Global initiative IDs keys that could unlock better personalized cancer treatments

(Parker Institute for Cancer Immunotherapy) Scientists from an initiative launched by the Parker Institute for Cancer Immunotherapy (PICI) and the Cancer Research Institute called the Tumor Neoantigen Selection Alliance (TESLA) have discovered parameters to better predict which neoantigens can stimulate a cancer-killing effect.